Geron lands potential $900M blood cancer drug deal with J&J By: San Francisco Business Times via Business Journals November 13, 2014 at 17:59 PM EST Geron Corp. will hand over its experimental blood cancer drug imetelstat to Johnson & Johnson's Janssen Biotech Inc... Read More >> Related Stocks: Johnson & Johnson